Native Top-Down Analysis of Intact Antibodies using Multiple Dissociation Techniques on a Tribrid Quadrupole Orbitrap Linear Ion Trap Mass Spectrometer

Posters | 2019 | Thermo Fisher Scientific | ASMSInstrumentation
LC/HRMS, LC/MS, LC/MS/MS, LC/Orbitrap
Industries
Pharma & Biopharma
Manufacturer
Thermo Fisher Scientific

Importance of the Topic


Therapeutic monoclonal antibodies are key biopharmaceuticals for oncology and autoimmune diseases. Top-down mass spectrometry offers direct analysis of intact proteins, preserving labile modifications and complex architectures, which is critical for comprehensive structural characterization.

Objectives and Study Overview


The study aims to assess the performance of the Thermo Scientific Orbitrap Eclipse Tribrid mass spectrometer under native conditions for top-down analysis of intact antibodies. It compares multiple dissociation techniques and contrasts native versus denaturing workflows to maximize sequence coverage and structural insight.

Methodology and Instrumentation


Analysis was performed using direct infusion electrospray in High Mass Range MSn (HMRn) mode with the Orbitrap Eclipse Tribrid quadrupole–Orbitrap–linear ion trap platform. Multiple fragmentation methods were applied:
  • High-energy collision dissociation (HCD)
  • Electron transfer dissociation (ETD)
  • Electron-transfer/higher-energy collision dissociation (EThcD)
  • Ultraviolet photodissociation (UVPD)
Sample preparation involved buffer exchange of trastuzumab (Herceptin) into 200 mM ammonium acetate for native analysis and a 1:1 acetonitrile:water solution with 0.1 % formic acid for denaturing experiments. Data processing used BioPharma Finder, TD Validator, Xtract, and ProSight Lite.

Main Results and Discussion


Native top-down analysis under non-denaturing conditions achieved 43 % combined sequence coverage, while denaturing conditions provided 39.7 %. By integrating native and denaturing data, total coverage rose to 53.3 %, with light chain coverage reaching 67.9 % and heavy chain 46.4 %. Fragmentation maps revealed complementary cleavage patterns across techniques, and Venn diagram analysis highlighted overlapping and unique residue cleavages between native and denatured states.

Benefits and Practical Applications


This approach delivers direct molecular weight determination, comprehensive sequence confirmation, localization of post-translational modifications such as glycosylation, and disulfide mapping without extensive sample preparation. It supports quality control and characterization workflows in biopharmaceutical development and regulatory compliance.

Future Trends and Opportunities


Advances in top-down instrumentation will enable higher resolution and faster scan rates, facilitating routine analysis of larger and more complex biotherapeutics. Integration with improved software tools and workflows promises automated data interpretation, expanded PTM mapping, and broader adoption in industrial and research laboratories.

Conclusion


The Thermo Scientific Orbitrap Eclipse Tribrid mass spectrometer demonstrates outstanding capability for native top-down analysis of intact antibodies, leveraging multiple dissociation methods to achieve high sequence coverage and detailed structural insights in a streamlined workflow.

References


No external references provided in the original document.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Thermo Scientific Orbitrap Eclipse Tribrid mass spectrometer
Thermo Scientific Orbitrap Eclipse Tribrid mass spectrometer
2020|Thermo Fisher Scientific|Brochures and specifications
In-depth characterization of monoclonal antibodies
In-depth characterization of monoclonal antibodies
2024|Thermo Fisher Scientific|Applications
Discovery with the Orbitrap Eclipse Tribrid mass spectrometer
Discovery with the Orbitrap Eclipse Tribrid mass spectrometer
2021|Thermo Fisher Scientific|Technical notes
Go beyond in biopharmaceutical characterization
Go beyond in biopharmaceutical characterization
2020|Thermo Fisher Scientific|Technical notes